We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
+13.38%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
-$106M
(-9.2%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-16.63%
Top 10 Holdings %
Top 10 Hldgs %
5.73%
Holding
1,387
New
364
Increased
246
Reduced
349
Closed
422
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$5.05M |
| 2 |
Century Aluminum
CENX
|
+$4.6M |
| 3 |
CBM
Cambrex Corporation
CBM
|
+$4.54M |
| 4 |
BBBY
Bed Bath & Beyond
BBBY
|
+$4.51M |
| 5 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
+$4.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OneSpan
OSPN
|
+$7.67M |
| 2 |
Lattice Semiconductor
LSCC
|
+$7.09M |
| 3 |
Mercury Insurance
MCY
|
+$5.38M |
| 4 |
Omnicell
OMCL
|
+$5.15M |
| 5 |
Maximus
MMS
|
+$4.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.11% |
| 2 | Technology | 14.11% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Industrials | 10.88% |
| 5 | Financials | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RT
401
DELISTED
Ruby Tuesday Georgia
RT
| $858K | 0.08% |
+125,462
| New | +$933K |
|
402
FerroAtlántica
GSM
$611M
| $857K | 0.08% |
49,710
+38,337
| +337% | +$664K |
|
|
NEWP
403
DELISTED
NEWPORT CORP
NEWP
| $857K | 0.08% |
44,837
-87,095
| -66% | -$1.57M |
|
404
FormFactor
FORM
$7.45B
| $855K | 0.08% |
99,386
-32,237
| -24% | -$253K |
|
405
Dycom Industries
DY
$12.4B
| $854K | 0.08% |
+24,338
| New | +$728K |
|
|
TTPH
406
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $854K | 0.08% |
1,075
-5,579
| -84% | -$3M |
|
|
ELME
407
Elme Communities
ELME
$145M
| $852K | 0.08% |
30,793
+8,467
| +38% | +$230K |
|
|
WG
408
DELISTED
Willbros Group
WG
| $851K | 0.08% |
135,771
+86,405
| +175% | +$493K |
|
|
LADR
409
Ladder Capital
LADR
$1.24B
| $847K | 0.08% |
53,843
+35,712
| +197% | +$549K |
|
410
National Beverage
FIZZ
$2.93B
| $846K | 0.08% |
+74,788
| New | +$896K |
|
411
Werner Enterprises
WERN
$2.42B
| $844K | 0.08% |
+27,091
| New | +$763K |
|
412
La-Z-Boy
LZB
$1.61B
| $842K | 0.08% |
+31,377
| New | +$741K |
|
413
US Physical Therapy
USPH
$1.16B
| $836K | 0.08% |
19,929
-4,414
| -18% | -$174K |
|
|
KEM
414
DELISTED
KEMET Corporation
KEM
| $836K | 0.08% |
199,048
+173,495
| +679% | +$732K |
|
415
Hilltop Holdings
HTH
$2.26B
| $834K | 0.08% |
+41,808
| New | +$859K |
|
416
Brixmor Property Group
BRX
$9.97B
| $832K | 0.08% |
33,490
-18,285
| -35% | -$437K |
|
417
Innospec
IOSP
$2.09B
| $832K | 0.08% |
+19,480
| New | +$798K |
|
|
ISBC
418
DELISTED
Investors Bancorp, Inc.
ISBC
| $830K | 0.08% |
73,939
-87,892
| -54% | -$934K |
|
419
Walker & Dunlop
WD
$1.67B
| $825K | 0.08% |
47,008
-17,591
| -27% | -$280K |
|
420
Patrick Industries
PATK
$2.81B
| $824K | 0.08% |
63,204
-89,775
| -59% | -$1.14M |
|
421
WSFS Financial
WSFS
$4.15B
| $821K | 0.08% |
32,040
-1,269
| -4% | -$32K |
|
|
EIGR
422
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $821K | 0.08% |
93
+40
| +75% | +$232K |
|
|
ALJ
423
DELISTED
Alon USA Energy Inc
ALJ
| $821K | 0.08% |
+64,829
| New | +$932K |
|
|
DF
424
DELISTED
Dean Foods Company
DF
| $820K | 0.08% |
42,320
+259
| +0.6% | +$4.12K |
|
|
NCFT
425
DELISTED
NORCRAFT COS INC COM STK (DE)
NCFT
| $820K | 0.08% |
+42,509
| New | +$758K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q4 2014 Portfolio in Review
As of Q4 2014, TFS Capital held 1,387 positions worth $1.05B, down 9.2% from $1.15B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
TFS Capital withdrew a net $174M in Q4 2014, closing 422 positions and reducing 349 holdings. Its most notable exit was Lattice Semiconductor, an estimated $7.09M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, TFS Capital opened a new position in Infinity Pharmaceuticals, Inc. worth $5.86M.
- TFS Capital's largest Q4 2014 buy was Infinity Pharmaceuticals, Inc.: 347,088 shares worth $5.86M.
- TFS Capital added most to Cambrex Corporation in Q4 2014, an estimated $4.54M increase.
- TFS Capital's biggest Q4 2014 reduction was OneSpan, cutting an estimated $7.67M.
- TFS Capital fully exited Lattice Semiconductor in Q4 2014, selling an estimated $7.09M.
- TFS Capital's ten largest holdings make up 5.7% of its $1.05B portfolio in Q4 2014.
- TFS Capital opened 364 new positions and closed 422 in Q4 2014.
- TFS Capital's portfolio value fell 9.2% quarter-over-quarter to $1.05B.
Based on TFS Capital's 13F filing for Q4 2014, filed 29 Jan 2015.